NILA News

3/30/2020
Trump Administration Engages America’s Hospitals in Unprecedented Data Sharing

Trump Administration Provides Financial Relief for Medicare Providers

3/27/2020
The CARES Act Provides Temporary, but Not Immediate Relief to Clinical Laboratories

Join the Next Clinical Laboratory COVID-19 Response Weekly Call on Monday, March 30 at 3:00 PM EDT

3/26/20
Senate Passes Stimulus Package with Relief for Clinical Laboratories

CMS Issues CLIA Guidance and FAQs for Laboratories During the COVID-19 Pandemic

3/24/2020
URGENT: NILA Members Call Your Senators Today

3/23/2020
CDC Weekly Call with Clinical Labs Audio and Transcript

3/21/2020
CDC Posts New Standard Operating Procedure for Creating Viral Transport Media

Discontinue Use of the A549/MV1LU Mix for Respiratory Viral Culture Panels and Review Updated Biosafety FAQs

3/20/2020
NILA's COVID-19 Stimulus Request Letter to Capitol Hill

Supplies Needed for COVID-19 Testing

3/19/2020
CDC to Convene Clinical Laboratory COVID-19 Response Weekly Calls Beginning on Monday, March 23, 2020 at 3:00 PM ET

3/17/2020
Change to Result Interpretation for CDC EUA Assay

3/15/2020
Lab Advisory: Updated Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19)

3/12/2020
COVID-19 Lab Letter to Vice President (PDF)

3/10/2020
CDC Updated Guidance on Testing Persons for Coronavirus Disease 2019 (COVID-19)

FDA releases FAQs on Diagnostic Testing for SARS-CoV-2 (COVID-19)

U.S. Department of Labor Offers Guidance For Preparing Workplaces for Coronavirus

3/9/2020
Coronavirus testing rollout marred by confusion and false starts (Yahoo! News)

3/5/2020
Lawmakers introduce legislation to expand nation’s diagnostic testing capabilities

Proper Handwashing Technique

3/4/2020
COVID-19 Public Health Reporting for Laboratories that Develop or Use Laboratory Developed Tests with Intent to Obtain EUA

3/2/2020
FDA Guidance to Develop Novel Molecular Diagnostic Tests for SARS-CoV-2

Laboratory Biosafety COVID-19 Frequently Asked Questions

2/27/2020
Criteria to Guide Evaluation of Person Under Investigation (PUI) for COVID-19

2/25/2020
Update: Public Health Response to the Coronavirus Disease 2019 Outbreak

2/24/2020
Public Health Response to the Coronavirus Disease 2019 Outbreak

2/21/2020
Frequently Asked Questions about Biosafety and COVID-19

2/18/2020 (from CRB)
Important FDA Notification Regarding Coronavirus

02/13/2020
NILA Posts Coronavirus Resource Center and News Page

02/12/2020
CMS Update on Coronavirus Assay

12/18/2019
PAMA Lawsuit - ACLA's Reply in Support of Plaintiff's Motion for Summary Judgment

12/17/2019
LAB Act Passes the House

12/13/2019
Senate Version (S. 3049) of the LAB Act Introduced

12/04/2019
Over 30 Lab Organizations Sign Letter to Congress Supporting Passage of the LAB Act (H.R. 3584)

11/06/2019
ALERT: FDA Issues Warning that Biotin may Interfere with Lab Tests, Especially Troponin

09/24/2019
U.S. Dept. of Labor Issues Final Overtime Rule

09/16/2019
Announcing NILA's 2020 Lab Leaders Forum and Mid-Winter Meeting

08/02/2019
Update on Successful Appeal in PAMA Lawsuit

Archived News

Click here to see NILA's archived news.